Study Reveals Ultrasound “Helmet” Could Revolutionize Parkinson’s Treatment
(MENAFN) A groundbreaking ultrasound “helmet” could revolutionize non-invasive therapies for Parkinson’s disease, according to a recent study.
Published in Nature Communications, the research reveals that "the newly developed system can reach brain regions 30 times smaller than conventional deep-brain devices," media reported Friday.
This innovative device delivers ultrasound with up to 1,000 times greater accuracy than traditional methods, offering a compelling alternative to deep brain stimulation (DBS) for neurological disorders.
Beyond Parkinson’s, this advanced technology holds potential to transform treatment for Tourette syndrome, chronic pain, depression, and Alzheimer’s disease.
DBS, the current standard, involves surgically implanting electrodes into targeted brain areas to regulate abnormal activity. In stark contrast, the new helmet eliminates the need for invasive surgery.
During trials, researchers successfully directed ultrasound waves precisely at the lateral geniculate nucleus, showcasing the device's remarkable effectiveness.
This breakthrough could mark a pivotal shift in neurological care, providing safer, more precise treatment options for millions.
Published in Nature Communications, the research reveals that "the newly developed system can reach brain regions 30 times smaller than conventional deep-brain devices," media reported Friday.
This innovative device delivers ultrasound with up to 1,000 times greater accuracy than traditional methods, offering a compelling alternative to deep brain stimulation (DBS) for neurological disorders.
Beyond Parkinson’s, this advanced technology holds potential to transform treatment for Tourette syndrome, chronic pain, depression, and Alzheimer’s disease.
DBS, the current standard, involves surgically implanting electrodes into targeted brain areas to regulate abnormal activity. In stark contrast, the new helmet eliminates the need for invasive surgery.
During trials, researchers successfully directed ultrasound waves precisely at the lateral geniculate nucleus, showcasing the device's remarkable effectiveness.
This breakthrough could mark a pivotal shift in neurological care, providing safer, more precise treatment options for millions.

Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- What Does The Europe Cryptocurrency Market Report Reveal For 2025?
- Japan Smart City Platform Market To Grow Worth USD 4.8 Billion By 2033 Exhibiting CAGR Of 11.7%
- Bitcoin Adoption On Sui Accelerates As Threshold Network And Sui Launch Phase 2 Of Tbtc Integration
- Japan Ultrasound Devices Market Size Worth USD 887.0 Million By 2033 CAGR Of 5.4%
- Primexbt Launches Empowering Traders To Succeed Campaign, Leading A New Era Of Trading
- Next Generation Management Corp. (OTC: NGMC) Announces Strategic Shift Toward Digital Commerce Acquisitions
Comments
No comment